Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Health & Fitness
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts123/v4/a0/a1/29/a0a129bb-c88a-c65c-5f0a-774df88dd07a/mza_17969811586559349542.jpg/600x600bb.jpg
Tech on Drugs with Shai Shen-Orr
CytoReason
12 episodes
2 months ago
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials.

It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
Show more...
Technology
RSS
All content for Tech on Drugs with Shai Shen-Orr is the property of CytoReason and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials.

It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
Show more...
Technology
https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/8ac5bc0b3429cb8b998ea23819f7b900.jpg
Tech On Drugs - Episode 3 - Prof. Yanay Ofran
Tech on Drugs with Shai Shen-Orr
34 minutes
2 years ago
Tech On Drugs - Episode 3 - Prof. Yanay Ofran
Our guest this time is serial biotech entrepreneur Yanay Ofran. Yanay is a renowned computational biophysicist and the CEO and Co-founder of Biolojic Design. More importantly, Yanay, together with his stellar team, developed the first AI-designed antibody. He shared with Shai his (strong) opinions about:
  • The barriers to precision medicine (and how to overcome them).
  • The potential of AI-designed antibodies (and how, just a few weeks ago, a cancer patient in North Carolina became the first American to receive treatment with such an antibody).
  • The reasons why even in this golden digital era drug development is still insanely expensive (and how - to use a battle metaphor - we've mastered the intelligence phase, we have great ammunition, but we need to seriously up the ante in execution!).
Enjoy!
Tech on Drugs with Shai Shen-Orr
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials.

It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.